Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Therapeutics × Clear all

NCT00415246 2019-11-22

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00305929 2010-06-02

Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure

Phase 2 Completed

Prostatic Neoplasms

NCT00312442 2010-06-02

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Phase 2/3 Terminated

Prostatic Neoplasms